HLA-I and breast cancer prognosis: a systematic review and meta-analysis
Hum. immunol; 85 (6), 2024
BACKGROUND: Breast cancer (BC) is a significant global health issue, accounting for 1 in 8 cancer diagnoses worldwide. HLA class I molecules are typically expressed on the cell surface, but cancer cells can develop mechanisms to evade recognition by CTLs, including the downregulation of HLA class I expre...